Turku Bioscience Centre at the University of Turku, Finland is using cutting-edge genomics methods to generate gene signature predicting type 1 diabetes. The signature is detectable already before the appearance of type 1 diabetes-associated autoantibodies. This finding could aid in the identification early on of children who are likely to develop the disease later in life.
The international study led by investigators from Turku Bioscience Centre at University of Turku, Finland, identified an early gene signature in children who will later develop type 1 diabetes—even before the appearance of the associated blood autoantibodies.
The results evidence a starting point for those investigators seeking to identify children who are likely to develop type 1 diabetes later in life. The team will need to validate and expand on these findings.
- Academy of Finland
- Juvenile Diabetes Research Foundation (USA)
- European Union
Riitta Lahesmaa, Academy Professor